Ametek Inc

$19.00

Want a discount? Become a member by purchasing Annual Subscription!
SKU: AME Category:

Description

In its Q4 2023 earnings, AMETEK showed strong financial performance and operational execution. The company reported record sales, operating income, earnings per share, EBITDA, and cash flow. Along with these, AMETEK ended the quarter with a record backlog. Moreover, the company also made strategic acquisitions, spending over $2 billion on Amplifier Research and Paragon Medical. This implies AMETEK’s growth model and business quality remain robust, contributing to its sustained success. In Q4 2023, its sales reached $1.73 billion, up 6.5% from Q4 2022, while its backlog grew 10% from the start of 2023 to $3.53 billion. The company’s operating income rose 12% from Q4 2022 to a record $445 million. EBITDA increased 8% year-over-year to a record $526 million. From these, AMETEK generated a record free cash flow of $481 million, up 47% from Q4 2022.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!